Generics Series: Key Trends and Events in the 7 Major Markets
Date Published:
December 19, 2007 Price:
$3,800.00 Source:
Datamonitor Scope
Report
Highlights
The
intensely competitive environment of the generics market is behind the
wave of consolidations that has resulted in a reshuffle of the top 10
generics companies globally.
Competitive
pressures have forced some generics companies out of the more mature
markets, while others have adopted novel strategies to survive.
Several
of the less mature markets, particularly Japan, in which generic uptake
has historically been slow, are poised for growth, and as such present
an attractive prospect for international players.
More stories about
More Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges
- Pharmaceuticals: United States Industry Guide
- Generic Benchmarking: Brand Erosion at Patent Expiry
- Key Players in Pharmaceutical Contract Manufacturing: Market developments, outsourcing hotspots and growth strategies
- The Future of Biobanks: Regulation, ethics, investment and the humanization of drug discovery




